1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Breast Lesion Guidance Systems Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Breast Lesion Guidance Systems by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Breast Lesion Guidance Systems by Country/Region, 2020, 2024 & 2031
2.2 Breast Lesion Guidance Systems Segment by Type
2.2.1 Wire-Guided Localization (WGL)
2.2.2 Magnetic Tracers
2.2.3 Electromagnetic Reflectors
2.2.4 Others
2.3 Breast Lesion Guidance Systems Sales by Type
2.3.1 Global Breast Lesion Guidance Systems Sales Market Share by Type (2020-2025)
2.3.2 Global Breast Lesion Guidance Systems Revenue and Market Share by Type (2020-2025)
2.3.3 Global Breast Lesion Guidance Systems Sale Price by Type (2020-2025)
2.4 Breast Lesion Guidance Systems Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 ASCs
2.4.4 Others
2.5 Breast Lesion Guidance Systems Sales by Application
2.5.1 Global Breast Lesion Guidance Systems Sale Market Share by Application (2020-2025)
2.5.2 Global Breast Lesion Guidance Systems Revenue and Market Share by Application (2020-2025)
2.5.3 Global Breast Lesion Guidance Systems Sale Price by Application (2020-2025)
3 Global Breast Lesion Guidance Systems by Company
3.1 Global Breast Lesion Guidance Systems Breakdown Data by Company
3.1.1 Global Breast Lesion Guidance Systems Annual Sales by Company (2020-2025)
3.1.2 Global Breast Lesion Guidance Systems Sales Market Share by Company (2020-2025)
3.2 Global Breast Lesion Guidance Systems Annual Revenue by Company (2020-2025)
3.2.1 Global Breast Lesion Guidance Systems Revenue by Company (2020-2025)
3.2.2 Global Breast Lesion Guidance Systems Revenue Market Share by Company (2020-2025)
3.3 Global Breast Lesion Guidance Systems Sale Price by Company
3.4 Key Manufacturers Breast Lesion Guidance Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Breast Lesion Guidance Systems Product Location Distribution
3.4.2 Players Breast Lesion Guidance Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Breast Lesion Guidance Systems by Geographic Region
4.1 World Historic Breast Lesion Guidance Systems Market Size by Geographic Region (2020-2025)
4.1.1 Global Breast Lesion Guidance Systems Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Breast Lesion Guidance Systems Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Breast Lesion Guidance Systems Market Size by Country/Region (2020-2025)
4.2.1 Global Breast Lesion Guidance Systems Annual Sales by Country/Region (2020-2025)
4.2.2 Global Breast Lesion Guidance Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Breast Lesion Guidance Systems Sales Growth
4.4 APAC Breast Lesion Guidance Systems Sales Growth
4.5 Europe Breast Lesion Guidance Systems Sales Growth
4.6 Middle East & Africa Breast Lesion Guidance Systems Sales Growth
5 Americas
5.1 Americas Breast Lesion Guidance Systems Sales by Country
5.1.1 Americas Breast Lesion Guidance Systems Sales by Country (2020-2025)
5.1.2 Americas Breast Lesion Guidance Systems Revenue by Country (2020-2025)
5.2 Americas Breast Lesion Guidance Systems Sales by Type
5.3 Americas Breast Lesion Guidance Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breast Lesion Guidance Systems Sales by Region
6.1.1 APAC Breast Lesion Guidance Systems Sales by Region (2020-2025)
6.1.2 APAC Breast Lesion Guidance Systems Revenue by Region (2020-2025)
6.2 APAC Breast Lesion Guidance Systems Sales by Type
6.3 APAC Breast Lesion Guidance Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Breast Lesion Guidance Systems by Country
7.1.1 Europe Breast Lesion Guidance Systems Sales by Country (2020-2025)
7.1.2 Europe Breast Lesion Guidance Systems Revenue by Country (2020-2025)
7.2 Europe Breast Lesion Guidance Systems Sales by Type
7.3 Europe Breast Lesion Guidance Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Breast Lesion Guidance Systems by Country
8.1.1 Middle East & Africa Breast Lesion Guidance Systems Sales by Country (2020-2025)
8.1.2 Middle East & Africa Breast Lesion Guidance Systems Revenue by Country (2020-2025)
8.2 Middle East & Africa Breast Lesion Guidance Systems Sales by Type
8.3 Middle East & Africa Breast Lesion Guidance Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Breast Lesion Guidance Systems
10.3 Manufacturing Process Analysis of Breast Lesion Guidance Systems
10.4 Industry Chain Structure of Breast Lesion Guidance Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Breast Lesion Guidance Systems Distributors
11.3 Breast Lesion Guidance Systems Customer
12 World Forecast Review for Breast Lesion Guidance Systems by Geographic Region
12.1 Global Breast Lesion Guidance Systems Market Size Forecast by Region
12.1.1 Global Breast Lesion Guidance Systems Forecast by Region (2026-2031)
12.1.2 Global Breast Lesion Guidance Systems Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Breast Lesion Guidance Systems Forecast by Type
12.7 Global Breast Lesion Guidance Systems Forecast by Application
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Breast Lesion Guidance Systems Product Portfolios and Specifications
13.1.3 BD Breast Lesion Guidance Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Hologic
13.2.1 Hologic Company Information
13.2.2 Hologic Breast Lesion Guidance Systems Product Portfolios and Specifications
13.2.3 Hologic Breast Lesion Guidance Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Hologic Main Business Overview
13.2.5 Hologic Latest Developments
13.3 Cianna Medical (Merit Medical)
13.3.1 Cianna Medical (Merit Medical) Company Information
13.3.2 Cianna Medical (Merit Medical) Breast Lesion Guidance Systems Product Portfolios and Specifications
13.3.3 Cianna Medical (Merit Medical) Breast Lesion Guidance Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cianna Medical (Merit Medical) Main Business Overview
13.3.5 Cianna Medical (Merit Medical) Latest Developments
13.4 Argon Medical Devices
13.4.1 Argon Medical Devices Company Information
13.4.2 Argon Medical Devices Breast Lesion Guidance Systems Product Portfolios and Specifications
13.4.3 Argon Medical Devices Breast Lesion Guidance Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Argon Medical Devices Main Business Overview
13.4.5 Argon Medical Devices Latest Developments
13.5 SOMATEX Medical
13.5.1 SOMATEX Medical Company Information
13.5.2 SOMATEX Medical Breast Lesion Guidance Systems Product Portfolios and Specifications
13.5.3 SOMATEX Medical Breast Lesion Guidance Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 SOMATEX Medical Main Business Overview
13.5.5 SOMATEX Medical Latest Developments
13.6 STERYLAB
13.6.1 STERYLAB Company Information
13.6.2 STERYLAB Breast Lesion Guidance Systems Product Portfolios and Specifications
13.6.3 STERYLAB Breast Lesion Guidance Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 STERYLAB Main Business Overview
13.6.5 STERYLAB Latest Developments
14 Research Findings and Conclusion
※参考情報 乳房病変ガイダンス装置(Breast Lesion Guidance Systems)は、乳房における病変の診断や治療を目的とした医療機器です。この装置は、乳癌や他の乳房疾患の早期発見、正確な位置特定、および適切な治療を可能にします。これにより、医師はより正確に病変にアプローチし、患者に対する負担を軽減しつつ、治療効果を向上させることができます。 まず、乳房病変ガイダンス装置の定義について説明します。これらの装置は、乳房内の腫瘤や病変に対して、画像診断技術を使用して位置を特定し、必要に応じて生検や治療を行うためのガイドとして機能します。主に超音波、マンモグラフィー、MRIなどの画像診断手法と組み合わせて使用されます。 乳房病変ガイダンス装置の特徴の一つは、その高精度な位置特定能力です。これにより、医師は小さな病変に対しても正確にアクセスでき、生検や局所麻酔下での治療を行うことが可能になります。また、これらの装置は、患者の快適性や安全性を考慮した設計がされている場合が多く、施行時の痛みや不快感を最小限に抑える工夫がなされています。 乳房病変ガイダンス装置の種類としてはいくつかのタイプがあります。代表的なものには、超音波ガイダンス装置、マンモグラフィーガイダンス装置、MRIガイダンス装置などがあります。超音波ガイダンス装置は、リアルタイムで病変を視覚化することができ、低侵襲の生検や治療が可能です。曼荼羅グラフィーガイダンスは、乳腺の構造を詳細に把握できるため、特定の病変に対して正確な治療が行えます。一方、MRIガイダンスは、特に高リスクの病変や複雑なケースに対して有用であり、より詳細な情報を提供します。 用途としては、まず生検が挙げられます。乳房病変ガイダンス装置は、病変の生検を行う際に、必要な部位に対して正確に針を挿入するために使用されます。これにより、組織サンプルを取得し、詳細な病理診断を行うことができ、患者に対する治療方針を決定するための重要な情報を得られます。また、一部の装置は、局所麻酔や簡単な治療(コールドコア生検や気泡によるマーカー挿入など)を行うことも可能です。 近年では、AI(人工知能)技術の進展も乳房病変ガイダンス装置の関連技術として注目されています。AIは、画像診断の解析や病変の自動検出、予測モデルなどの分野で活用されており、診断精度向上やワークフローの効率化に寄与しています。AIを組み込むことで、乳房病変の早期発見や診断の標準化が進み、医療従事者の負担軽減にもつながります。 加えて、乳房病変ガイダンス装置は、患者のリスク評価に基づく個別化医療の一環としても重要です。乳癌のリスク因子を評価した上で、適切なスクリーニングや治療の選択を支援します。これにより、患者一人ひとりに最適な治療を提供し、全体的な治療成績を向上させることが期待されます。 結論として、乳房病変ガイダンス装置は、乳癌や他の乳房疾患の診断・治療において、不可欠な役割を果たしています。その高精度な技術によって、医療の質が向上し、患者のQOL(生活の質)の向上にも寄与しています。これからも技術の進歩に伴い、さらに多様な機能が追加され、より効果的に乳房疾患へのアプローチが行われることが期待されています。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/